Tower Research Capital LLC (TRC) - PROTALIX BIOTHERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,210
+116.2%
6,753
+160.5%
0.00%
Q2 2023$5,184
+172700.0%
2,592
+61.8%
0.00%
Q1 2023$3
-100.0%
1,602
-75.2%
0.00%
Q1 2022$7,0006,465
+8879.2%
0.00%
Q4 2021$0
-100.0%
72
-98.5%
0.00%
Q2 2021$9,000
+80.0%
4,658
+328.1%
0.00%
Q1 2021$5,0001,0880.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,413,487$2,513,0000.04%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$27,0000.02%
MEITAV INVESTMENT HOUSE LTD 244,332$256,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,790$139,0000.00%
IHT Wealth Management, LLC 22,000$23,0000.00%
Psagot Value Holdings Ltd. / (Israel) 6,000$6,0000.00%
Smith Salley Wealth Management 12,048$13,0000.00%
BANK OF AMERICA CORP /DE/ 3,027$3,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
DAVENPORT & Co LLC 22,000$23,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders